Matching targets for selective cancer therapy (Q34284156)

1 August 2017

Matching targets for selective cancer therapy (English)

1 reference

1 August 2017

1

Mikhail V Blagosklonny

1 reference

1 August 2017

1 December 2003

1 reference

1 August 2017

1 reference

1 August 2017

8

1 reference

1 August 2017

1104-1107

1 reference

1 August 2017

24

1 reference

Perspectives on the development of a molecularly targeted agent

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Improving the evaluation of new cancer treatments: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Why Iressa failed: toward novel use of kinase inhibitors (outlook).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Integrating genetic approaches into the discovery of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Choosing anticancer drug targets in the postgenomic era.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Therapeutic exploitation of checkpoint defects in cancer cells lacking p53 function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Codominant interference, antieffectors, and multitarget drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Selective killing of transformed baby hamster kidney (BHK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Cyclotherapy: protection of normal cells and unshielding of cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

1 reference

7 January 2021

Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

A new science-business paradigm in anticancer drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

More Than One Road to Kill Tumor Cells: Why Are They Not Always Successful?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Apoptosis-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Apoptosis-targeted therapies for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902806-X

7 January 2021

10.1016/S1359-6446(03)02806-X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

14678733